New data from Japan shows early resolution of common Covid-1

Japanese pharmaceutical company Shionogi has announced the first peer-reviewed publication of its phase 3 study investigating ensitrelvir to treat patients with mild to moderate COVID-19 in Japan, South Korea and Vietnam.

Related Keywords

Japan , Singapore , Takeki Uehara , Yohei Doi , Ministry Of Health , Fujita Health University , World Health Organization , Drug Administration , Special Access Route , Fast Track , Clinical Development , Covid 19 , Coronavirus , Clinical Trials ,